Molina Healthcare’s (MOH) “Overweight” Rating Reaffirmed at Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Molina Healthcare (NYSE:MOH) in a report released on Thursday, Benzinga reports. The brokerage currently has a $406.00 price target on the stock.

Several other analysts have also weighed in on the company. Truist Financial decreased their price objective on Molina Healthcare from $440.00 to $400.00 and set a “buy” rating on the stock in a report on Monday, July 15th. StockNews.com raised shares of Molina Healthcare from a “hold” rating to a “buy” rating in a report on Friday, October 18th. TD Cowen dropped their price objective on shares of Molina Healthcare from $412.00 to $351.00 and set a “buy” rating for the company in a research note on Wednesday, July 24th. Stephens reiterated an “equal weight” rating and set a $320.00 target price on shares of Molina Healthcare in a research report on Thursday, July 25th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating for the company in a research report on Wednesday, July 10th. One analyst has rated the stock with a sell rating, six have issued a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $367.00.

Molina Healthcare Trading Up 0.6 %

Shares of MOH stock opened at $325.54 on Thursday. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.49. Molina Healthcare has a 1 year low of $272.69 and a 1 year high of $423.92. The firm’s fifty day simple moving average is $335.23 and its 200 day simple moving average is $329.39. The firm has a market capitalization of $19.08 billion, a P/E ratio of 17.66, a price-to-earnings-growth ratio of 0.99 and a beta of 0.58.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, October 23rd. The company reported $6.01 EPS for the quarter, beating analysts’ consensus estimates of $5.96 by $0.05. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The business had revenue of $10.34 billion during the quarter, compared to analyst estimates of $9.92 billion. During the same quarter in the prior year, the business earned $5.05 earnings per share. The firm’s revenue for the quarter was up 21.0% on a year-over-year basis. As a group, sell-side analysts predict that Molina Healthcare will post 23.5 EPS for the current year.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the transaction, the director now owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Molina Healthcare news, CAO Maurice Hebert sold 393 shares of the firm’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $346.52, for a total value of $136,182.36. Following the completion of the sale, the chief accounting officer now owns 9,473 shares in the company, valued at approximately $3,282,583.96. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the transaction, the director now owns 18,025 shares in the company, valued at $6,114,260.25. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. Innealta Capital LLC bought a new position in Molina Healthcare in the 2nd quarter valued at $36,000. Ashton Thomas Private Wealth LLC acquired a new stake in Molina Healthcare in the second quarter worth about $40,000. AM Squared Ltd acquired a new position in Molina Healthcare during the 2nd quarter valued at about $59,000. UMB Bank n.a. boosted its stake in shares of Molina Healthcare by 96.2% in the 3rd quarter. UMB Bank n.a. now owns 206 shares of the company’s stock valued at $71,000 after purchasing an additional 101 shares during the last quarter. Finally, Fidelis Capital Partners LLC bought a new position in shares of Molina Healthcare in the 1st quarter valued at about $151,000. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.